Guardant Health, Inc.
—- Market cap
- —
- Debt
- +$1.50B
- Cash
- −$378.20M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: GH stock price vs KO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at KO's multiple
Needs KO P/S.
Implied fair value · at GH's multiple
Needs GH P/S.
Metric by metric
Where each company leads, and how wide the gap is.
Price unavailable
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GH FY 2025 (ended Dec 31, 2025) · KO FY 2025 (ended Dec 31, 2025).
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
GUARDANT HEALTH, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
COCA COLA CO · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-15.14x
1.36x
Net debt / EBITDA
Leverage against operating earnings
-3.04x
1.69x
Cash and equivalents
Liquid reserves on the balance sheet
$378.20M
$12.20B
Total debt
Interest-bearing obligations outstanding
$1.50B
$43.61B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
NEOGENOMICS INC
GH vs NEO
Fulgent Genetics, Inc.
GH vs FLGT
EXACT SCIENCES CORP
GH vs EXAS
Natera, Inc.
GH vs NTRA
PEPSICO INC
GH vs PEP
Keurig Dr Pepper Inc.
GH vs KDP
Monster Beverage Corp
GH vs MNST
NATIONAL BEVERAGE CORP
GH vs FIZZ
MOLSON COORS BEVERAGE CO
GH vs TAP
HERSHEY CO
GH vs HSY
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.